- Email: [email protected]
Predominance of Allergic Bronchopulmonary Aspergillosis (ABPA) in African Americans With Cystic Fibrosis
October 2013, Vol 144, No. 4_MeetingAbstracts Genetic and Developmental Disorders | October 2013
Predominance of Allergic Bronchopulmonary Aspergillosis (ABPA) in African Americans With Cystic Fibrosis Sumaira Malik, MBBS; Nauman Chaudary, MBBS UMMC, Jackson, MS Chest. 2013;144(4_MeetingAbstracts):587A. doi:10.1378/chest.1675284
Abstract SESSION TITLE:Cystic Fibrosis/ Bronchiectasis Posters SESSION TYPE: Origina l Investigation Poster PRESENTED ON: Wednesday, October 30, 2013 at 01:30 PM - 02:30 PM PURPOSE: Factors associated with Allergic bronchopulmonary aspergillosis (ABPA) and Cystic Fibrosis (CF) include age, gender, atopy, severity of lung disease and coloni zation with Pseudomonas.
Because of the difficulties of recognizing ABPA in
context of cystic fibrosis as there are overlapping clinical, radiographic, microbiologic and immunologic features common to both diseases, recognizing ABPA in CF can be challengin g and often delayed. This can potentially lead to decline in lung function starting early in life. Considering that CF patients undergo multiple medication treatments early on during the course of their illness with resultant alterations in their immunity, anti -aspergillus fumigatus IgE may be more predictive of ABPA diagnosis and severity than the stringent diagnostic criteria itself. We hypothesize that ABPA is predominant in African American adults with CF as compared to Caucasians
and
consider serologic specific Immunoglobulin E (IgE) levels as a gold standard for the diagnosis of ABPA. METHODS: We did a retrospective chart review of our adult cystic fibrosis center patients enrolled in cystic fibrosis registry. Prevalence of ABPA was compared in African Americans and Caucasians.
Patients were diagnosed as having ABPA if serum
anti -aspergillus fumigatus IgE levels were elevated as confirmed on radioallergosorbent test (RAST).
RESULTS: Five out of six African American CF patients had elevation of total IgE levels. Two African American had elevated anti -aspergillus fumigatus IgE levels suggesting a diagnosis of ABPA. Three African Americans with significant elevation of total IgE did not have anti -aspergillus fumigatus IgE levels drawn. Six out of forty nine Caucasian CF patients had elevated anti -aspergillus IgE levels and total IgE levels. Three Caucasians
had elevated IgE total but did not have anti -aspergillus fumigatus IgE
drawn. F508 del genotype was present in all caucasian patients with ABPA and CF. CONCLUSIONS: 1. Although incidence of CF is lower in African American population, prevalence of ABPA may be higher among those diagnosed with CF. 2. Anti-aspergillus fumigatus IgE levels are rapid and cost effective in ABPA resulting in early treatment rath er than following all of stringent criteria. 3. Simplified criteria in ABPA may also lead to earlier recognition of ABPA and may assist with preservation of lung function in CF patients if treated early. CLINICALIMPLICATIONS:Anti-aspergillus fumigatus therapy with anti IgE may also prove to be of significant benefit in CF patient with ABPA. DISCLOSURE: The following authors have nothing to disclose: Sumaira Malik, Nauman Chaudary No Product/Research
Disclosure Information
Predominance of Allergic Bronchopulmonary Aspergillosis (ABPA) in African Americans With Cystic Fibrosis Sumaira Malik, MBBS; Nauman Chaudary, MBBS UMMC, Jackson, MS Chest. 2013;144(4_MeetingAbstracts):587A. doi:10.1378/chest.1675284
Abstract SESSION TITLE:Cystic Fibrosis/ Bronchiectasis Posters SESSION TYPE: Origina l Investigation Poster PRESENTED ON: Wednesday, October 30, 2013 at 01:30 PM - 02:30 PM PURPOSE: Factors associated with Allergic bronchopulmonary aspergillosis (ABPA) and Cystic Fibrosis (CF) include age, gender, atopy, severity of lung disease and coloni zation with Pseudomonas.
Because of the difficulties of recognizing ABPA in
context of cystic fibrosis as there are overlapping clinical, radiographic, microbiologic and immunologic features common to both diseases, recognizing ABPA in CF can be challengin g and often delayed. This can potentially lead to decline in lung function starting early in life. Considering that CF patients undergo multiple medication treatments early on during the course of their illness with resultant alterations in their immunity, anti -aspergillus fumigatus IgE may be more predictive of ABPA diagnosis and severity than the stringent diagnostic criteria itself. We hypothesize that ABPA is predominant in African American adults with CF as compared to Caucasians
and
consider serologic specific Immunoglobulin E (IgE) levels as a gold standard for the diagnosis of ABPA. METHODS: We did a retrospective chart review of our adult cystic fibrosis center patients enrolled in cystic fibrosis registry. Prevalence of ABPA was compared in African Americans and Caucasians.
Patients were diagnosed as having ABPA if serum
anti -aspergillus fumigatus IgE levels were elevated as confirmed on radioallergosorbent test (RAST).
RESULTS: Five out of six African American CF patients had elevation of total IgE levels. Two African American had elevated anti -aspergillus fumigatus IgE levels suggesting a diagnosis of ABPA. Three African Americans with significant elevation of total IgE did not have anti -aspergillus fumigatus IgE levels drawn. Six out of forty nine Caucasian CF patients had elevated anti -aspergillus IgE levels and total IgE levels. Three Caucasians
had elevated IgE total but did not have anti -aspergillus fumigatus IgE
drawn. F508 del genotype was present in all caucasian patients with ABPA and CF. CONCLUSIONS: 1. Although incidence of CF is lower in African American population, prevalence of ABPA may be higher among those diagnosed with CF. 2. Anti-aspergillus fumigatus IgE levels are rapid and cost effective in ABPA resulting in early treatment rath er than following all of stringent criteria. 3. Simplified criteria in ABPA may also lead to earlier recognition of ABPA and may assist with preservation of lung function in CF patients if treated early. CLINICALIMPLICATIONS:Anti-aspergillus fumigatus therapy with anti IgE may also prove to be of significant benefit in CF patient with ABPA. DISCLOSURE: The following authors have nothing to disclose: Sumaira Malik, Nauman Chaudary No Product/Research
Disclosure Information